Level Zero Health, a female-founded medical device startup, recently secured $6.9 million in an oversubscribed pre-seed funding round. The startup is developing a non-invasive device for continuous hormone monitoring to replace traditional blood draws, with hopes of advancing treatments related to hormone imbalances. Co-founder Ula Rustamova expressed ambitions to create a new market akin to continuous glucose monitors. As they work towards a broader product category, the team is also developing a single-use product to support hormone testing for specific medical conditions.
Level Zero Health aims to revolutionize hormone monitoring with a non-invasive device, bolstered by a successful $6.9 million pre-seed funding round.
Collection
[
|
...
]